TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04731233

Efficacy of PRGF Supplementation After TMJ Arthrocentesis in Patients With TMJ Osteoarthritis

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“Could not recruit participants due to their refusal to be randomized in the study.”

The sponsor’s own words in the registry.

Life of this trial

202120222023202420252026Registered2021-01-26Started2021-03-30Stopped2024-02-21Results posted2025-02-21

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
University of Florida
Sponsor type
University, hospital or other
Conditions
TMJ; Osteoarthritis
Interventions
Plasma Rich in Growth Factor (PRGF) Supplementation; Triamcinolone Acetonide
Participants
5
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.